This protocol addresses women presenting with mild hirsutism in whom evaluation has found no evidence of an underlying endocrine disorder. The absence of a detectable hormonal or glandular cause is the defining feature of this scenario and directly informs the initial management decision.
When hirsutism is graded as mild and no endocrine pathology is identified, clinical guidance supports two distinct management categories as equivalent first-line options. Either approach is appropriate — selection is guided by individual patient circumstances rather than a strict clinical hierarchy.
First-line management involves a choice between a pharmacological route and a direct procedural approach, with the specific method within each category determined by patient characteristics. The complete selection criteria and clinical algorithm are in the structured protocol.
DOI: 10.1210/jc.2018-00241
However, for women with mild hirsutism and no evidence of an endocrine disorder, we suggest either approach. (2 |OOO)
We now suggest either pharmacologic therapy or direct hair removal methods as initial therapy for women with mild hirsutism and no evidence of an endocrine disorder.
View source ↗